Brief: Percheron Therapeutics Seeks Trading Halt
25/06/2025 02:11
June 25 (Reuters) - Percheron Therapeutics Ltd PER.AX: SEEKS TRADING HALT PENDING ANNOUNCEMENT ON LICENSING TRANSACTION. Further company coverage: PER.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Percheron Therapeutics
See all newsBrief: Invion Announces Preclinical Research Collaboration With Percheron Therapeutics
Brief: Percheron Therapeutics Receives Firm Commitments For A$2.3 Million Institutional Placement
Brief: Percheron Therapeutics Appoints Ambrosini as Interim Board Member During CEO Transition Period
Brief: Percheron Therapeutics Says Vanderbilt Health To Conduct Clinical Trial Of Hmbd-002 In Acute Myeloid Leukaemia
Brief: Percheron Therapeutics Says James Garner To Step Down As CEO And Managing Director